1 Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic -Cells

2 Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.

3 A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.

4 Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives.

5 Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.

6 Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Emergency Reversal of Vitamin K Antagonists: A Meta-Analysis in 2606 Subjects.

7 Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

8 Long-Term Vitamin K Antagonists and Cancer Risk: A Systematic Review and Meta-Analysis.

9 Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients

10 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis

11 Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study

12 Use of vitamin K antagonists and risk of prostate cancer: Meta–analysis and nationwide case–control study

13 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis

14 Comment on “Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis”

15 DOACs vs Vitamin K Antagonists: a Comparison of Phase III Clinical Trials and a Prescriber Support Tool

16 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

17 Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

18 Patient Reported Outcomes Following Initiation of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes in a Specialist Endocrinology Practice of the LMC Diabetes Registry: The PROGRESS-Diabetes Study.

19 The possible synergistic action of sex hormones and glucagon-like peptide-1 (GLP-1) agonists on body mass decline in patients with type 2 diabetes mellitus.

20 Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin

21 GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

22 Evidence-based comparison of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors.

23 Evaluation of the effects of commonly used α-adrenergic receptor agonists alone and in combination with butorphanol tartrate on objective measurements of lameness in horses.

24 Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma

25 Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter ABCG2

26 Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan

27 A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.

28 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018).

29 The AMPA receptor binding site: focus on agonists and competitive antagonists.

30 Patent evaluation: Isatine AMPA antagonists

31 Isatine AMPA antagonists

32 Effect of constant light and immobilization stress on rat submandibular saliva secretory response induced by cholinergic and peptidergic agonists

33 Author-characters and authorial public image: The elderly protagonists in philip roth and nicole krauss

34 Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis.

35 β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists.

36 An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

37 Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P receptor agonists.

38 QSAR models on H receptor antagonists associated with inflammation and anaphylaxis.

39 New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.

40 Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists.

41 Down-regulation of vimentin by triorganotin isothiocyanates - nuclear retinoid X receptor agonists: A proteomic approach.

42 Bacterial antagonists and hexanal-induced systemic resistance of mango fruits against lasiodiplodia theobromae causing stem-end rot

43 PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.

44 A contemporary overview of PPARα/γ dual agonists for the management of diabetic dyslipidemia

45 Between an ugly truth and a perfect lie: Wiping off fearful memories using beta-adrenergic receptors antagonists.

46 Effect of NMDA and AMPA/kainate receptor antagonists against ethambutol induced retinal toxicity using optomotor response (OMR) in goldfish

47 Preclinical optimization of gp120 entry-antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation.

48 Corrigendum to “Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer” (European Journal of Medicinal Chemistry (2019) 163 (787–803), (S0223523418310614), (10.1016/j.ejmech.2018.12.024))

49 Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease mice.

50 Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists.

51 Structural features and functional activities of benzimidazoles as NOD2 antagonists

52 Effect of specific retinoic acid receptor agonists on noise-induced hearing loss

53 Identification of novel peptide agonists from a random peptide library for a 5-oxo-ETE receptor, a receptor for bioactive lipids.

54 Antagonists D1 and D2 of Dopamine Receptors Determine Different Mechanisms of Neuroprotective Action in the Frog Vestibular.

55 Mineralocorticoid receptor antagonists for heart failure

56 Gold Nanoparticles Functionalized with Peptides for Specific Affinity Aggregation Assays of Estrogen Receptors and Their Agonists

57 Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

58 Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial

59 Adrenergic agonists do not compete with the antagonist (−)3-[125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor

60 18f-labeled grpr agonists and antagonists: a comparative study in prostate cancer imaging

61 novel glun2b selective nmda receptor antagonists: relative configuration of 7-methoxy-2-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-1-ols

62 a high expression egfr/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening egfr antagonists from rhizoma polygoni cuspidati

63 micrornas signatures, bioinformatics analysis of mirnas, mirna mimics and antagonists, and mirna therapeutics in osteosarcoma

64 incretin-like effects of small molecule trace amine-associated receptor 1 agonists

65 cellular and biophysical pipeline for the screening of peroxisome proliferator-activated receptor beta/delta agonists: avoiding false positives

66 eicosopentaneoic acid and other free fatty acid receptor agonists inhibit lysophosphatidic acid- and epidermal growth factor-induced proliferation of human breast cancer cells

67 examining portrayals of female protagonists by female screenwriters using feminist critical discourse analysis.

68 trpv1 antagonists and chronic pain: beyond thermal perception

69 a clinical review of glp-1 receptor agonists: efficacy and safety in diabetes and beyond

70 ace inhibitors – angiotensin ii receptor antagonists: a useful combination therapy for ischemic heart disease

71 novel ffa1 (gpr40) agonists containing spirocyclic periphery: polar azine periphery as a driver of potency

72 toll-like receptor 9 agonists for cancer therapy

73 discovery of potential orthosteric and allosteric antagonists of p2y1r from chinese herbs by molecular simulation methods

74 environmental toxin acrolein alters levels of endogenous lipids, including trp agonists: a potential mechanism for headache driven by trpa1 activation

75 growth suppression activity of bradykinin antagonists in glioma cells

76 dihydropyridine calcium antagonists: data of evidence based medicine and recom-mendations on practical use

77 determination of multiresidue analysis of β-agonists in muscle and viscera using liquid chromatograph/tandem mass spectrometry with quick, easy, cheap, effective, rugged, and safe methodologies

78 luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. a standard approach and the results of innovative studies

79 renin-angiotensin system antagonists, glomerular filtration rate and blood pressure

80 leukotriene receptor antagonists in the treatment of asthma: implications for eosinophilic inflammation

81 molecular encapsulation of histamine h2-receptor antagonists by cucurbit[7]uril: an experimental and computational study

82 5-ht2b receptor antagonists inhibit fibrosis and protect from rv heart failure

83 tre protagonisti dell’architettura neoclassica a trieste: matteo pertsch, antonio mollari, pietro nobile / three protagonists of the neoclassical architecture in trieste: matteo pertsch, antonio mollari, pietro nobile

84 modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors

85 choosing between glp-1 receptor agonists and dpp-4 inhibitors: a pharmacological perspective

86 5-ht1a receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice

87 the use of thrombopoietin receptor agonists for correction of thrombocytopenia prior to elective procedures in chronic liver diseases: review of current evidence

88 alpha-adrenoceptor antagonists improve memory by activating -methyl-d-aspartate-induced ion currents in the rat hippocampus

89 pparγ agonists in adaptive immunity: what do immune disorders and their models have to tell us?

90 discovery of natural products as novel and potent fxr antagonists by virtual screening

91 the effect of glutamate receptor agonists on mouse retinal astrocyte [ca2+]i

92 pinpointing brainstem mechanisms responsible for autonomic dysfunction in rett syndrome: therapeutic perspectives for 5-ht1a agonists

93 novel agonists for serotonin 5-ht7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and fmr1 ko mice, a model of fragile x syndrome

94 histamine h3 receptor inverse agonists on cognitive and motor processes: relevance to alzheimer’s disease, adhd, schizophrenia and drug abuse

95 angiotensin ii type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes

96 diversity and characterization of endophytic fungi isolated from the tropical mangrove species, rhizophora mucronata, and identification of potential antagonists against the soil-borne fungus, fusarium solani

97 mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine

98 mechanistic target of rapamycin (mtor): a point of convergence in the action of insulin/igf-1 and g protein-coupled receptor agonists in pancreatic cancer cells

99 a quantitative structure–activity relationship study of tetrabutylphosphonium bromide analogs as muscarinic acetylcholine receptors agonists

100 spectrofluorimetric method for determination of some angiotensin ii receptor antagonists

101 cumarinas, interacción con anticoagulantes antagonistas de la vitamina k y seguridad del haba tonka coumarins: interaction with vitamin k antagonists and safety of tonka bean

Keyword Connections

Journals

Research Groups

Bibliographies